Large Clinical Trial Will Test Combination Monoclonal Antibody Therapy for Mild-to-Moderate COVID-19
Image courtesy of NIAID A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who have mild or…